1st Quarter - Report

BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) for BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)

Firm
Client
Income
—
Expenses
$190,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Agriculture, Rural Development, Food and Drug Administration,and Related Agencies Appropriations Labor, Health and Human Services, and Education,and Related Agencies Appropriations

LobbyistCovered position, as disclosed
AARON W HUNTER —
NIELS KNUTSON New —
LAURA WHITTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

S. 1948, H.R. 3709 -- Chronic Disease Management Act of 2019 Issues in the House of Representatives related to amending the Internal Revenue Code, with respect to health savings accounts (HSAs), to allow the high deductible health plans required for an HSA to provide care for chronic conditions with no deductible - discussions outside the scope of S. 1948 and H.R. 3709.

LobbyistCovered position, as disclosed
AARON W HUNTER —
LAURA WHITTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3709 (116th), S. 1948 (116th)

Health Issues HCR

S. 1895 - Lower Health Care Costs Act H.R. 2668 - Special Diabetes Program Reauthorization Act of 2019 H.R. 2680 - Special Diabetes Program for Indians Reauthorization Act of 2019 H.R. 2328 - Reauthorizing and Extending Americas Community Health Act (REACH Act) H.R. 965 - CREATES Act of 2019 S. 2543 - The Prescription Drug Pricing Reduction Act of 2019 S. 2199, H.R. 4906 - Insulin Price Reduction Act S. 2004, H.R. 4010 -- Emergency Access to Insulin Act of 2019 H.R. 3 - Lower Drug Costs Now Act of 2019 S. 2855 - Insulin Affordability Data Collection Act H.R. 19, S. 3129 - Lower Costs, More Cures Act of 2019 Issues and legislation related to drug pricing, specifically as it relates to insulin Issues and legislation related to a passthrough of any/all savings to beneficiaries using insulin in Medicare Part D. Issues and legislation related to providing flexibility in the split of a deductible between devices and prescription drugs Issues related to the importance of preserving health insurance protections for individuals with pre-existing conditions. H.R. 5254 - Diabetic Vision Loss and Blindness Prevention Act of 2019 Issues relates to expanding telehealth under Medicare for the purposes of qualifying visits for insulin pumps and continuous glucose monitors. S. 3548, H.R. 748 - CARES Act

LobbyistCovered position, as disclosed
AARON W HUNTER —
NIELS KNUTSON New —
LAURA WHITTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 748 (116th), H.R. 5254 (116th), H.R. 4010 (116th), H.R. 4906 (116th), S. 2543 (116th), S. 1895 (116th), H.R. 2668 (116th), S. 2855 (116th), S. 3129 (116th), H.R. 3 (116th), S. 3548 (116th), S. 2004 (116th), H.R. 2680 (116th), H.R. 965 (116th), S. 2199 (116th), H.R. 19 (116th), H.R. 2328 (116th)

Small Business SMB

S. 3548, H.R. 748 - CARES Act

LobbyistCovered position, as disclosed
AARON W HUNTER —
NIELS KNUTSON New —
LAURA WHITTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 748 (116th), S. 3548 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.